Parathormon, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients

Area of Science:

• Nephrology
• Cardiology
• Endocrinology

Background:

• Clinical data link Parathormone (PTH), calcium, and phosphorus to left ventricular hypertrophy (LVH) and myocardial contractility issues in end-stage renal disease.
• Cellular calcium overload and fibrosis from PTH may impair left ventricular diastolic function.
• Hyperphosphatemia is an independent cardiovascular mortality risk in dialysis patients.

Purpose of the Study:

• To assess the impact of PTH and calcium-phosphorus metabolism on left ventricular structure and function.
• To compare echocardiographic findings between normotensive and hypertensive hemodialysis (HD) patients.
• To evaluate relationships between PTH, mineral metabolism, and echocardiographic parameters in normotensive HD patients.

Main Methods:

• Echocardiography was used to compare 22 normotensive HD patients with 43 hypertensive HD patients.
• Relationships between PTH, calcium-phosphorus metabolism, and echocardiographic parameters were analyzed in the normotensive group.
• Statistical analysis (correlation) was performed to identify significant associations.

Main Results:

• Normotensive HD patients had lower left ventricular mass index (LVMI) and LVH prevalence than hypertensive patients.
• Significant correlations were found between PTH and LVMI, calcium and posterior wall thickness, and phosphorus and LVMI in normotensive patients.
• Phosphorus, calcium x phosphorus product, and E/A ratio showed significant correlations with diastolic function parameters.

Conclusions:

• Disturbances in calcium-phosphorus metabolism and secondary hyperparathyroidism contribute to LVH.
• These metabolic derangements also lead to impaired left ventricular diastolic function in normotensive HD patients.
• PTH and mineral imbalances are critical factors affecting cardiac structure and function in HD patients.